« Physician Payment Sunshine Act: CMS Launches National Physician Payment Transparency Program Website, Forms and Templates | Main | HHS OIG Report: FDA Lacks Comprehensive Data to Determine Whether Risk Evaluation and Mitigation Strategies (REMS) Improve Drug Safety »

February 22, 2013

TrackBack

TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e5520572bb8834017ee89c9231970d

Listed below are links to weblogs that reference HHS OIG: Listing of Pharmaceutical and Device Corporate Integrity Agreements:

Comments

Feed You can follow this conversation by subscribing to the comment feed for this post.

The comments to this entry are closed.

Sponsors

Enter your Email:
Preview | Powered by FeedBlitz

November 2014

Sun Mon Tue Wed Thu Fri Sat
            1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30